On September 21, 2026, a Phase 2 clinical trial changed status to active, not recruiting. The study, registered as NCT07225829, is titled "A Trial to Investigate the Safety and Efficacy of Intra-articular 4P004 Injection in Subjects With Knee Synovitis and Osteoarthritis."
This trial is evaluating intra-articular 4P004 injections in participants with knee synovitis and osteoarthritis. The current phase listed is Phase 2. The status update indicates the trial is no longer enrolling new participants but remains ongoing for those already involved.
No results or outcome data have been posted for this trial as of this update. The record reflects only a change in recruitment status, not findings related to safety or efficacy. Details on trial design, endpoints, and further updates can be found in the official registry listing.
Liraglutide is an approved compound, and this trial update is part of the broader research landscape tracked for the drug. Readers interested in liraglutide's approved uses and background can consult the compound overview for additional context.